Crispin R. Dass

Research interests

Publications

• Breast cancer bone metastases: pathogenesis and therapeutic targets

  The International Journal of Biochemistry & Cell Biology · 2018 · https://doi.org/10.1016/j.biocel.2018.01.003

• Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment

  Journal of Controlled Release · 2017 · https://doi.org/10.1016/j.jconrel.2017.09.003

• Oral insulin delivery: existing barriers and current counter-strategies

  Journal of Pharmacy and Pharmacology · 2017 · https://doi.org/10.1111/jphp.12852

• Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin

  International Journal of Pharmaceutics · 2017 · https://doi.org/10.1016/j.ijpharm.2017.12.036

• Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities

  Journal of Pharmacy and Pharmacology · 2016 · https://doi.org/10.1111/jphp.12607

• Current research on pharmacologic and regenerative therapies for osteoarthritis

  Bone Research · 2016 · https://doi.org/10.1038/boneres.2015.40

• Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism

  Journal of Pharmacy and Pharmacology · 2016 · https://doi.org/10.1111/jphp.12539

• Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

  Journal of Pharmacy and Pharmacology · 2012 · https://doi.org/10.1111/j.2042-7158.2012.01567.x

• Targeted therapy for cancer using pH-responsive nanocarrier systems

  Life Sciences · 2012 · https://doi.org/10.1016/j.lfs.2012.01.008

• The Molecular Pathogenesis of Osteosarcoma: A Review

  Sarcoma · 2011 · https://doi.org/10.1155/2011/959248

• Osteosarcoma treatment: state of the art

  Cancer and Metastasis Reviews · 2009 · https://doi.org/10.1007/s10555-009-9186-7

• Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery

  Peptides · 2009 · https://doi.org/10.1016/j.peptides.2009.10.002

• Bim-targeted cancer therapy: A link between drug action and underlying molecular changes

  Molecular Cancer Therapeutics · 2009 · https://doi.org/10.1158/1535-7163.mct-09-0685

• A chitosan–dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma

  Biomaterials · 2009 · https://doi.org/10.1016/j.biomaterials.2009.03.022

• DNAzyme technology and cancer therapy: cleave and let die

  Molecular Cancer Therapeutics · 2008 · https://doi.org/10.1158/1535-7163.mct-07-0510

• Injectable chitosan hydrogels for localised cancer therapy

  Journal of Controlled Release · 2008 · https://doi.org/10.1016/j.jconrel.2007.11.018

• Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway

  Molecular Cancer Therapeutics · 2008 · https://doi.org/10.1158/1535-7163.mct-08-0530

• A review of clinical and molecular prognostic factors in osteosarcoma

  Journal of Cancer Research and Clinical Oncology · 2007 · https://doi.org/10.1007/s00432-007-0330-x

• Brothers in Arms

  American Journal Of Pathology · 2007 · https://doi.org/10.2353/ajpath.2007.070120

• RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer

  Cancer and Metastasis Reviews · 2007 · https://doi.org/10.1007/s10555-007-9093-8

• PEDF: a potential molecular therapeutic target with multiple anti-cancer activities

  Trends in Molecular Medicine · 2006 · https://doi.org/10.1016/j.molmed.2006.08.009

• Effect of Deoxyribozymes Targeting c-Jun on Solid Tumor Growth and Angiogenesis in Rodents

  JNCI Journal of the National Cancer Institute · 2004 · https://doi.org/10.1093/jnci/djh120

• Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth

  Nature Medicine · 2003 · https://doi.org/10.1038/nm905

• Cellular Uptake, Distribution, and Stability of 10-23 Deoxyribozymes

  Antisense and Nucleic Acid Drug Development · 2002 · https://doi.org/10.1089/108729002761381276

Current projects

No projects listed.